Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Five Prime Therapeutics to Present at Upcoming Healthcare Conference


Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics today announced that Aron Knickerbocker, Chief Executive Officer, is scheduled to present at the following investor conference:

The presentations will be webcast and may be accessed at the "Events & Presentations" section of the Company's website at:

http://investor.fiveprime.com/events.cfm. Five Prime will maintain an archived replay of the webcast on its website for 30 days after the conference.

About Five Prime

Five Prime Therapeutics, Inc. discovers and develops innovative protein therapeutics to improve the lives of patients with serious diseases. Five Prime's product candidates have innovative mechanisms of action and address patient populations in need of better therapies. The company focuses on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with Five Prime's product candidates. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com or follow us on LinkedIn, Twitter and Facebook.

Source: Five Prime Therapeutics, Inc.


These press releases may also interest you

at 16:15
Universal Logistics Holdings, Inc. Named a 2023 Supplier of the Year by General Motors
Universal Logistics Holdings, Inc. was named a 2023 Supplier of the Year by General Motors ("GM"). GM celebrated honorees at its 32nd annual Supplier of the Year event in Miami, Florida last week....

at 16:10
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 16:10
Smartsheet Announces $150 Million Share Repurchase Program
Smartsheet , the enterprise work management platform, today announced that its Board of Directors has authorized the repurchase of up to $150 million of the company's outstanding Class A common stock through open market purchase, block trades, and/or...

at 15:57
Slovenia Signs Artemis Accords, Joins Pursuit of Safer Space
NASA and Slovenia affirmed their cooperation in future space endeavors on Friday as Slovenia became the 39th country to sign the Artemis Accords. The signing certified Slovenia's commitment to pursue safe and sustainable exploration of space for the...

at 15:55
Valley Mountain Regional Center Provides Notice Following Data Security Incident
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...

More news about Science and technology...


News published on and distributed by: